Improving the accuracy of pancreatic cancer clinical staging by exploitation of nanoparticle-blood interactions: A pilot study

Pancreatic ductal adenocarcinoma (PDAC) early diagnosis is  crucial  and new, cheap and user-friendly techniques for biomarker identification  are  needed. “Protein corona” (PC) is emerging a new bio-interface potentially useful in tumor early diagnosis. In a previous investigation, we showed that r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2018-09, Vol.18 (6), p.661-665
Hauptverfasser:	Caputo, D., Cartillone, M., Cascone, C., Pozzi, D., Digiacomo, L., Palchetti, S., Caracciolo, G., Coppola, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Aged Aged, 80 and over Biomarkers Biomarkers for pancreatic ductal adenocarcinoma Cancer Carcinoma, Pancreatic Ductal - blood Carcinoma, Pancreatic Ductal - pathology Chemotherapy Data processing Diagnosis Early Diagnosis Electrophoresis, Polyacrylamide Gel Endoscopy Family medical history Female Gel electrophoresis Humans Lipids Liposomes - blood Male Medical imaging Metastases Metastasis Middle Aged Molecular Weight Nanoparticles Nanoparticles - analysis Nanotechnology Neoplasm Metastasis Neoplasm Staging Pancreatic adenocarcinoma clinical stage Pancreatic cancer Pancreatic ductal adenocarcinoma Pancreatic Neoplasms - blood Pancreatic Neoplasms - pathology Pilot Projects Plasma proteins Prognosis Protein corona Proteins Sodium lauryl sulfate Statistical analysis Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!